Literature DB >> 8788103

In vivo biocompatibility study of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks.

B Ronneberger1, W J Kao, J M Anderson, T Kissel.   

Abstract

Films of three ABA-block copolymers composed of lactic-co-glycolic acid A blocks and poly(oxyethylene) (PEO) B blocks and one random lactic-co-glycolic acid copolymer (PLG) were studied to investigate the influence of different polymer compositions and molecular weights on the tissue reaction, appearance of toxic degradation products, and swelling behavior in the cage implant system in rats. The inflammatory tissue reaction was followed over a 21-day implantation period by monitoring the leukocyte concentration, the extracellular acid, and alkaline phosphatase activities in a quantitative manner. Size and density of adherent macrophages and foreign body giant cells on the film surfaces were determined. The ABA and PLG implants caused only a minimal inflammatory reaction, as characterized by a low concentration of leukocytes during the implantation period when compared to empty cage controls. The content of PEO had an influence on the density of the adherent cells on the surface of the polymer film. An increase in PEO content and molecular weight decreased the cellular density during the implantation period. As demonstrated by scanning electron microscopy, no degradation was observed for all polymers during the implantation period. Our results demonstrate that the ABA block copolymers and PLG copolymer, are equally well tolerated in the cage implant test system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8788103     DOI: 10.1002/(SICI)1097-4636(199601)30:1<31::AID-JBM5>3.0.CO;2-S

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  19 in total

1.  Controlled release of insulin from injectable biodegradable triblock copolymer.

Authors:  Y J Kim; S Choi; J J Koh; M Lee; K S Ko; S W Kim
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

Review 2.  Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts.

Authors:  James D Bryers; Cecilia M Giachelli; Buddy D Ratner
Journal:  Biotechnol Bioeng       Date:  2012-05-24       Impact factor: 4.530

Review 3.  Recent advances in intravesical drug/gene delivery.

Authors:  Pradeep Tyagi; Pao-Chu Wu; Michael Chancellor; Naoki Yoshimura; Leaf Huang
Journal:  Mol Pharm       Date:  2006 Jul-Aug       Impact factor: 4.939

4.  Anti-inflammatory polymeric coatings for implantable biomaterials and devices.

Authors:  Amanda W Bridges; Andrés J García
Journal:  J Diabetes Sci Technol       Date:  2008-11

5.  Reduced acute inflammatory responses to microgel conformal coatings.

Authors:  Amanda W Bridges; Neetu Singh; Kellie L Burns; Julia E Babensee; L Andrew Lyon; Andrés J García
Journal:  Biomaterials       Date:  2008-09-19       Impact factor: 12.479

Review 6.  Biomaterials/tissue interactions: possible solutions to overcome foreign body response.

Authors:  Jacqueline M Morais; Fotios Papadimitrakopoulos; Diane J Burgess
Journal:  AAPS J       Date:  2010-02-09       Impact factor: 4.009

7.  A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response.

Authors:  Yoshinori Onuki; Upkar Bhardwaj; Fotios Papadimitrakopoulos; Diane J Burgess
Journal:  J Diabetes Sci Technol       Date:  2008-11

8.  In vivo biodegradation and biocompatibility of PEG/sebacic acid-based hydrogels using a cage implant system.

Authors:  Jinku Kim; Mahrokh Dadsetan; Syed Ameenuddin; Anthony J Windebank; Michael J Yaszemski; Lichun Lu
Journal:  J Biomed Mater Res A       Date:  2010-10       Impact factor: 4.396

9.  Phase separation at the surface of poly(ethylene oxide)-containing biodegradable poly(L-lactic acid) blends.

Authors:  Jinxiang Yu; Christine M Mahoney; Albert J Fahey; Wesley L Hicks; Robert Hard; Frank V Bright; Joseph A Gardella
Journal:  Langmuir       Date:  2009-10-06       Impact factor: 3.882

10.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.

Authors:  R Gref; A Domb; P Quellec; T Blunk; R H Müller; J M Verbavatz; R Langer
Journal:  Adv Drug Deliv Rev       Date:  1995-09       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.